Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years with or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)

  • Laura L. Hammitt
  • , Dean Quinn
  • , Ewa Janczewska
  • , Francisco J. Pasquel
  • , Richard Tytus
  • , K. Rajender Reddy
  • , Katia Abarca
  • , Ilsiyar M. Khaertynova
  • , Ron Dagan
  • , Jennifer McCauley
  • , Kyeongmi Cheon
  • , Alison Pedley
  • , Tina Sterling
  • , Gretchen Tamms
  • , Luwy Musey
  • , Ulrike K. Buchwald

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years with or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry